Patents by Inventor Hans-Dieter Lenke

Hans-Dieter Lenke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4267187
    Abstract: Alkylaminopropanol derivatives of 2-(o-hydroxyphenyl)-pyrrole of the formula (I) ##STR1## where R is hydrogen or is alkyl of 1 to 8 carbon atoms which is unsubstituted or substituted by hydroxyl, alkoxy of 1 to 3 carbons atoms or cycloalkyl of 3 to 8 carbon atoms in the ring, or is alkenyl or alkynyl of 2 to 8 carbon atoms or is cycloalkyl or cycloalkenyl of 3 to 8 carbon atoms in the ring, the cycloalkyl rings being unsubstituted or monosubstituted or disubstituted by alkyl or 1 to 3 carbon atoms, and their physiologically acceptable acid addition salts, processes for their preparation, and pharmaceutical formulations which contain the said compounds and may be used in the treatment of cardiac and circulatory disorders.
    Type: Grant
    Filed: August 8, 1979
    Date of Patent: May 12, 1981
    Assignee: BASF Aktiengesellschaft
    Inventors: Fritz-Frieder Frickel, Albrecht Franke, Horst Koenig, Hans-Dieter Lenke, Josef Gries
  • Patent number: 4124716
    Abstract: Process for the treatment of spasmodic conditions in humans by administering a compound of the general formula ##STR1## or a pharmacologically acceptable acid addition salt thereof to a human suffering from such conditions.
    Type: Grant
    Filed: October 14, 1977
    Date of Patent: November 7, 1978
    Assignee: Asta-werke Aktiengesellschaft
    Inventors: Peter Emig, Hans Pohle, Gerhard Scheffler, Norbert Brock, Hans-Dieter Lenke, Jorg Pohl
  • Patent number: 4065501
    Abstract: The present invention is related to new basic enol ethers having the general formula ##STR1## and to the pharmacologically acceptable acid addition salts thereof. The invention is further related to process for the treatment of spasmodic conditions in humans by administering a compound of the above general formula or a pharmacologically acceptable acid addition salt thereof to a human suffering from such conditions.
    Type: Grant
    Filed: March 12, 1975
    Date of Patent: December 27, 1977
    Assignee: Asta-Werke Aktiengesellschaft
    Inventors: Peter Emig, Hans Pohle, Gerhard Scheffler, Norbert Brock, Hans-Dieter Lenke, Jorg Pohl